The MEP Interest Group 2023 Conference “COUNTDOWN TO EU ELECTIONS: How can policymakers secure the promise of Advanced Therapies for patients over the next 6 months?”, organised by the European Alliance for Transformative Therapies (TRANSFORM) was held last October...
admin_eptri
Home /
Approval of AGAMREE® for the treatment of DMD paediatric patients on the horizon!
The Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion in favor of the approval of AGAMREE® (vamorolone) for the treatment of Duchenne Muscular Dystrophy (DMD) patients aged 4 years and older. Vamorolone is a novel drug candidate...
EPTRI BoD Member Donato Bonifazi at the Enpr-EMA annual workshop
On 10 October 2023, the 2023 annual workshop of the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) presented an opportunity for stakeholders to come together and exchange ideas to improve clinical trials for children. The event...
EPTRI Webinar – Investment and commercial opportunities in child health technology
Our first webinar “Investment and commercial opportunities in child health technology” chaired by Paul Dimitri, was held on September 5th. This webinar, organized by our Paediatric Medical Device Research Platform, is part of a one year online educational programme...
Neonatal immune activation by lipopolysaccharide causes inadequate emotional responses
Neonatal immune activation by lipopolysaccharide causes inadequate emotional responses to novel situations but no changes in anxiety or cognitive behavior in Wistar rats. Iveta Vojtechova, Tomas Petrasek, Kristyna Maleninska, Hana Brozka, Hana Tejkalova, Jiri Horacek,...
Bridging the gaps of the paediatric excellence medicine
Adriana Ceci, Catherine Tuleu, Donato Bonifazi, Hana Kubova, Irmgard Toni, Marialuisa Lavitrano, Mariangela Lupo, Valeria Pignataro British Journal of Pharmacy DOI: 10.5920/bjpharm.614 https://www.bjpharm.org.uk/article/id/614/
EPTRI has entered in the Italian Roadmap for Research Infrastructures
On 20 October 2021, the Decree of the Italian Minister of University and Research adopting the National Research Infrastructure Plan (PNIR) 2021-2027 as an integral part of the National Research Program 2021-2027 (PNR) was published. The European Paediatric...
Twelfth EPTRI Newsletter!
Dear Colleagues,
I am happy to share with you the October issue of the EPTRI Newsletter which sees the EPTRI participation in several important paediatric research initiatives.
1st International Conference on Rare Diseases and Paediatric Research
The 1st International Conference on Rare Diseases and Paediatric Research will be held for the first time virtually on 18-19 November 2021! The Conference is organised by 95, Rare Alliance Greece together with Consorzio per Valutazioni Biologiche e Farmacologiche...
SEMMELWEIS SYMPOSIUM, November 16-18, 2021, Budapest, Hungary
The EPTRI Coordinator, Dr. Donato Bonifazi, will participate in the meeting having a presentation entitled: ‘European Paediatric Translational Research Infrastructure: contribution to a new frontier in paediatrics’. Semmelweis Symposium 2021 is one of the most...